MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products. In addition, the company exports its products to East Asia, Southeast Asia, the Middle East, South America, and Africa. The company was formerly known as Advik Laboratories Limited and changed its name to MPS Pharmaa Limited in December 2022. MPS Pharmaa Limited was incorporated in 1994 and is based in New Delhi, India.
Metrics to compare | ADLB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADLBPeersSector | |
---|---|---|---|---|
P/E Ratio | −5.0x | −0.1x | −0.5x | |
PEG Ratio | 1.09 | 0.09 | 0.00 | |
Price/Book | 4.2x | 1.0x | 2.6x | |
Price / LTM Sales | 102.8x | 0.8x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 40.6% | |
Fair Value Upside | Unlock | 7.4% | 5.3% | Unlock |